[{"address1": "116 Huntington Avenue", "address2": "Suite 703", "city": "Boston", "state": "MA", "zip": "02116", "country": "United States", "phone": "617 468 4219", "website": "https://www.bicara.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.", "fullTimeEmployees": 55, "companyOfficers": [{"maxAge": 1, "name": "Dr. Claire  Mazumdar Clemon M.B.A., Ph.D.", "age": 34, "title": "CEO & Director", "yearBorn": 1990, "fiscalYear": 2024, "totalPay": 829800, "exercisedValue": 0, "unexercisedValue": 5023506}, {"maxAge": 1, "name": "Mr. Ryan  Cohlhepp Pharm.D.", "age": 47, "title": "President, COO & Director", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 825750, "exercisedValue": 0, "unexercisedValue": 2526259}, {"maxAge": 1, "name": "Mr. Ivan  Hyep M.B.A.", "age": 39, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 915375, "exercisedValue": 0, "unexercisedValue": 1986752}, {"maxAge": 1, "name": "Ms. Lara S. Meisner J.D.", "age": 51, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rachel  Salazar", "title": "SVP of R&D Strategy and Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sathish  Hasige Ph.D.", "title": "Senior VP and Head of Technical Operations & Supply Chain", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Raben M.D.", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela  Windt", "title": "VP & Head of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeltje  Schulten M.B.A., M.D.", "title": "Senior Vice President of Clinical & Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jean-Paul  Rodrique", "title": "Senior VP & Global Head of Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.43, "open": 9.55, "dayLow": 9.08, "dayHigh": 9.7779, "regularMarketPreviousClose": 9.43, "regularMarketOpen": 9.55, "regularMarketDayLow": 9.08, "regularMarketDayHigh": 9.7779, "payoutRatio": 0.0, "forwardPE": -5.78882, "volume": 539239, "regularMarketVolume": 539239, "averageVolume": 833650, "averageVolume10days": 635970, "averageDailyVolume10Day": 635970, "bid": 9.26, "ask": 9.38, "bidSize": 1, "askSize": 4, "marketCap": 508277376, "fiftyTwoWeekLow": 7.8, "fiftyTwoWeekHigh": 28.09, "fiftyDayAverage": 12.3458, "twoHundredDayAverage": 16.2456, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 46803552, "profitMargins": 0.0, "floatShares": 28482631, "sharesOutstanding": 54536200, "sharesShort": 6578158, "sharesShortPriorMonth": 6495930, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.12060001, "heldPercentInsiders": 0.116459996, "heldPercentInstitutions": 0.89282, "shortRatio": 6.32, "shortPercentOfFloat": 0.18879999, "impliedSharesOutstanding": 54536200, "bookValue": 8.417, "priceToBook": 1.1072829, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -92333000, "trailingEps": -1.69, "forwardEps": -1.61, "enterpriseToEbitda": -0.43, "52WeekChange": -0.60187954, "SandP52WeekChange": 0.09544468, "quoteType": "EQUITY", "currentPrice": 9.32, "targetHighPrice": 48.0, "targetLowPrice": 8.0, "targetMeanPrice": 32.6, "targetMedianPrice": 36.0, "recommendationMean": 1.57143, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 462064992, "totalCashPerShare": 8.473, "ebitda": -108741000, "totalDebt": 591000, "quickRatio": 24.167, "currentRatio": 24.621, "debtToEquity": 0.129, "returnOnEquity": -0.27258, "operatingCashflow": -88270000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BCAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1750463319, "regularMarketTime": 1750449602, "exchange": "NGM", "messageBoardId": "finmb_674698236", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.1665, "regularMarketPrice": 9.32, "shortName": "Bicara Therapeutics Inc.", "longName": "Bicara Therapeutics Inc.", "fiftyTwoWeekHighChange": -18.77, "fiftyTwoWeekHighChangePercent": -0.6682093, "fiftyTwoWeekChangePercent": -60.187954, "earningsTimestamp": 1747135849, "earningsTimestampStart": 1755001800, "earningsTimestampEnd": 1755001800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.69, "epsForward": -1.61, "epsCurrentYear": -2.28167, "priceEpsCurrentYear": -4.0847273, "fiftyDayAverageChange": -3.0258007, "fiftyDayAverageChangePercent": -0.24508744, "twoHundredDayAverageChange": -6.9256, "twoHundredDayAverageChangePercent": -0.42630622, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-09-13", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1726234200000, "postMarketChangePercent": 5.15022, "postMarketPrice": 9.8, "postMarketChange": 0.48, "regularMarketChange": -0.110001, "regularMarketDayRange": "9.08 - 9.7779", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 833650, "fiftyTwoWeekLowChange": 1.5199995, "fiftyTwoWeekLowChangePercent": 0.19487172, "fiftyTwoWeekRange": "7.8 - 28.09", "marketState": "CLOSED", "displayName": "Bicara Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-06-21"}]